Earnings call transcript: EverCommerce Q4 2025 earnings miss hits stock

EverCommerce reported Q4 2025 EPS of $0.03, missing the $0.05 consensus by 40%, while revenue was $151.2M, 0.56% above estimates and +5.2% YoY. Adjusted gross profit was $117M (77.5% margin) and adjusted EBITDA was $44.2M (29.2% margin, flat YoY); the stock plunged 17.76% to $10.05 in regular trading (aftermarket $11.75). Management reiterated an AI-first strategy, provided FY2026 revenue guidance of $612M–$632M and Adjusted EBITDA $183M–$191M, expects EPS of $0.17–$0.19 for remaining 2026 quarters, and repurchased 2.5M shares for $24.8M in Q4.

Analysis

The market punished EverCommerce on the margin miss because investors had priced in near-term operating leverage from prior optimization efforts; however, the company’s pivot to AI and voice agents means the P&L will intentionally carry higher fixed product investment before revenue reacceleration. That sequencing creates a two-speed thesis: downside near-term sensitivity to cash flow and guide slippage, but a convex upside if cross-sell + payments monetization and agentic features convert at scale. Expect the stock to trade on quarter-to-quarter execution beats/misses into H1–H2 2026 while the durable payoff from AI manifests over 12–24 months.

Payments and product mix are the key second-order drivers. Concentration in a smaller set of “top” solutions accelerates TPV growth but increases revenue cyclicality and execution risk if those funnels stall; conversely, wins in payment attach and onboarding automation would translate into disproportionately higher incremental EBITDA because payments are reported net and sit at very high gross margins. Practical read-through: track monthly TPV cadence, new-customer payment attach rate, and reactivation metrics as leading indicators of margin inflection.

ZyraTalk and proprietary SMB voice/interaction data provide a defensible differentiation versus generic AI stacks, but the moat is execution- and compliance-led — HIPAA/regulatory friction, transcription accuracy, and workflow integration will determine monetization timing. A realistic timeline is GA → paid rollout → measurable ARPU lift across cohorts over 3–8 quarters; failure modes include slower adoption, higher churn if features are buggy, or regulatory pushback that forces redesign.

Short-term catalysts to watch (days–months): Q1 cash flow and guide cadence, sequential NRR, and any commentary on pricing/packaging changes. Medium-term (6–18 months) catalysts: ZyraTalk broad integrations, measurable TPV acceleration in top solutions, and margin expansion from AI-driven automation which would re-rate the multiple.

Key Decisions for Investors

• Tactical short EVCM equity (entry ≤ $11): size 1–2% of portfolio, target 30–40% downside over 3–6 months if Q1 cadence/NRR weaken. Place stop-loss at +12% to limit drawdown; catalyst = continued EPS/CF misses and softer payment attach metrics.
• Long-dated, limited-risk AI upside: buy EVCM Jan 2028 $12/$25 call spread (size small, 0.5–1% risk budget) funded by selling a small position of Jul 2026 $12 calls. Rationale = preserves upside capture from successful ZyraTalk monetization while limiting premium outlay; expect payoff window 12–24 months if agentic features show ARPU lift.
• Hedge the short via pair volatility: for every short 100 shares EVCM, purchase 1–2 OTM Jan 2028 $15 calls as protection (long-tail convexity). This keeps downside exposure to operational misses but caps catastrophic risk if AI adoption re-rates the stock quickly; monitor attach rate and TPV monthly for rebalancing signals.